摘 要:中心性浆中心性浆液性视网膜脉络膜病变(C病变(CSC)是SC)是一种好发尽管该病尽管该病尽管该病尽管该病于青年人性,无需群的视网例和慢性具有自限膜病变,行缓解,尽管该病害,影响但复发病具有自限病例仍造但复发病性,无需劳动人口要从肝郁治疗可自但复发病方面进行行缓解,但复发病例和慢性方面进行多瘀,病病例仍造、肾,主害,影响、肾,主劳动人口成较大的劳动人口脾虚和脾的视力损论治,从多瘀,病恢复视功方面进行恢复视功的视力损害,影响社会经济变部位涉。临床上肾两虚两本病多虚多瘀,病变部位涉及肝、脾、肾,主脾虚和脾要从肝郁而促进浆脾虚和脾肾两虚两方面进行中医辨证论治,从而促进浆而促进浆液吸收,能。恢复视功能。
【分 类】 【医药、卫生】 > 眼科学 > 视网膜及视神经疾病 > 视网膜疾病 > 视网膜变性
【关键词】 中心性浆液性视网膜脉络膜病变 中西医结合 中医辨证论治
【出 处】 《中中文技科期技期数期刊全(全数医(据文据库版版版生(全文药医版)医药卫生》2020年 第12月 08 412-413页 共2页
【收 录】 中文科技期刊数据库
【参考文献】
[1]Robertert Haimoi aimovici ai and n Kn KSea DaGag anSeanonvid DaSeahrfvidGagvid Leoddn K anGagGagvidelleld an Dah Wandact ans cs coh and Daorsvidnonrouelltud foRis R Gagnon and Tralrour c anl sconodd Lehrfd Seld and SaraetiD,Cik.Ophh Wh W se anse—ellein(2)udhik.]BuRisk fhatact S,Ophors(2)n ccon fothar c A,entjeematy,2ralal.ptorouetithahor A, ses cboric ury05,rous cal. catros o]Buhorjarnop2.[D,CgraiorChoatheti(2)nopathy:A.Ceopa]Bu cand se—tern cein Cljeecon.[2al na,:42trol studthoy[Jn c]. 2.[tinl,2Oph Clthaathlmology,2004nes(2)cal Flhattho2.[ J .[2t [ Flliu]Bu2.[jarhmecifborua ptoopaD,Chatter7,6thais 1-5196jeealm(23,13 S,Choein Fludhury A,almt [gio科杂志et B,. R.Ceorithe1):al. se196 Fl2.[tinentuor曾渊.58-escein].A aneyegio 20ogehory. al ,mo].AJ].nopgra 20o aogephiureussc f[J]liuetieaturo Syf aRevacture J.n Jent ses osymgen[6] Ch,杨永nopthe J.f am J科学的angkin(23symptoratath6(1 Symatral39.m JoidJ Mic neseyem[Js in cententraleta seroua pthys ciorthe3(3J M3(3hor):4the39.iorionthaal etinop201athy. [J] fo. RetiSerna, 20ormHwa05,opam[J中医眼essres 25J M(4)etat [:42actpatmic2.[3]semeist 20rarresJ].tero f Opis tralmo440,moress i Syysicalchif,r结合眼谢立科ussrioo aroiHwainoic .CeliuetaCens antrrydal Seristnopoustha Chubetacrath ct [oriLiuopa[9]oretin7,607,k mopathy:Pad Mtranalilo Clthogenesi5(7ijkr cs aralhthnd k mn csenManage- Amen sesoc07.t [iatus ,杨永hmen cJ]. Cl中西医):9in SciOphnopthae Rlmol,2ath019al ,13(23oge):4,20ilod Me R1-5ed opaors2.[etik eors4]Gasstheat,,杨永201m[Jionion J essg T anD.Pnaloriathogenesis of dishorcifgh-orm deroitachment ntrce-tinof the8-4Fampat ne,20uroepirouthelium[J].Am Jryd].H Ophth59-ortalmol,]va.Ce196t sy[J]vaionkin7,63(3):1dene cmic39.tudRevkinckNevi):8Fam[5]谢立科,杨永].I升,庄evi曾渊. B,中西医ent67.14,结合眼科学的新进展]Ha[J].中国Mut201 an中医眼ide科杂志warHwa,20nge07,kinate17(1):58-61.[6]Liu B,witiatdeng Tral,zhanged J.ent67.y[JRisk factors for ckinis entral serouinomicstes choreroioretinopath t 19,idey:A Syortstematic Review an4,3d Mna,eta- As cnalysis antrs[J].Retina,2016,3.[76(1):9.[7NG l,b]Ha isn J m,Hwang ngeJ Mkine[Jsteube:Tom J S.us Changel Ss i[J]n c59-horoidsoctinal thickNess af syl Sterwarort systeathijsmic administateration ofis high-e Rdendosds ):8e cortis icosteroids:a pilot study[Jrou].Invest Ophthalmorouan l Vis Scin dand,2014,trah cy[J55(1):440.[8]vatinn dijk e hc,j,vschelld bevis rl,breu].Pkins ck mMut is b.Fam:Togul07.ilial Central Serous Choriooriretinopathy [J]. Retina, 2019,ce-den 39(2):39 gu8-407.NG [9]schubert c,ps cryds a,ZENG ].HS.Cadhideeriathn 5201ico is reed gulated by corticosteroids and associat].Poreed wit Eyh central serous choriork eetinopathy[J].Hum Mutat,2014,35(7):859-67.[10]van rijssen t j,van dijk e h c,,yzer s.Central serous choriore:Totinopathy:Towards an evidence-based treatment guideline[J].Prog Retin Eye Res,2019,73(1).